• Pitt
  • Health Sciences
  • UPMC
Regenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan InstituteRegenerative Medicine at the McGowan Institute
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Statistics
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2021 Scientific Retreat
    • Human Performance Optimization Conference

Newsletter 2014

Newsletter
Media Newsletter 2014

Newsletters | December 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | December 23, 2014
Illustration: Stem cells found in the human limbus (the region between the cornea and the sclera, the white part of the eye) can be used to prevent the scarring of corneal tissue. Credit: C. Bickel/ AAAS.

December 2014 | VOL. 13, NO. 12 | www.McGowan.pitt.edu

Patient’s Own Stem Cells Could Clear a Cloudy Cornea

Treating the potentially blinding haze of a scar on the cornea might be as straightforward as growing stem cells from a tiny biopsy of the patient’s undamaged eye and then placing them on the injury site, according to pre-clinical model experiments conducted by McGowan Institute for Regenerative Medicine affiliated faculty members James Funderburgh, PhD, Yiqin Du, MD, PhD, and researchers at the University of Pittsburgh School of Medicine. The findings, published in Science Translational Medicine, could one day rescue vision for millions of people worldwide and decrease the need for corneal transplants.

Read More

Newsletters | November 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | November 28, 2014
McGowan faculty member Dr. Eric Lagasse

November 2014 | VOL. 13, NO. 11 | www.McGowan.pitt.edu

Team Discovers Stem Cells in the Esophagus—Could Lead to New Models to Study Esophageal Disease

Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said senior investigator Eric Lagasse, PharmD, PhD, associate professor of pathology, Pitt School of Medicine, and director of the Cancer Stem Cell Center at the McGowan Institute for Regenerative Medicine, and researchers from the University of Pittsburgh School of Medicine in an animal study published online in Cell Reports. The findings could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett’s esophagus.

Read More

Newsletters | October 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | October 31, 2014
drs_l and_s_v

October 2014 | VOL. 13, NO. 10 | www.McGowan.pitt.edu

Needle Treatment for Glaucoma Shows Promise: A Monthly Injection That Might Replace Eye Drops Used Twice Daily

As reported by Ann Lukits of the Wall Street Journal, Pittsburgh scientists led by McGowan Institute for Regenerative Medicine faculty member Steven Little, PhD, chairman of the Department of Chemical and Petroleum Engineering and associate professor and CNG faculty fellow in the Departments of Chemical and Petroleum Engineering, Bioengineering, Immunology, and Ophthalmology, are working to develop new techniques to administer medication for glaucoma patients that replace the usual regimen of twice-daily eye drops, a sometimes unreliable treatment. McGowan Institute for Regenerative Medicine faculty member Joel Schuman, MD, Eye and Ear Foundation professor and chairman of the Department of Ophthalmology, with secondary appointments as professor of bioengineering and of clinical and translational science, and professor at the Center for the Neural Basis of Cognition, a University of Pittsburgh/Carnegie Mellon University collaboration, was a member of the research team as well.

Read More

Newsletters | September 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | September 30, 2014
TissuGlu® receives a positive recommendation from a U.S. Food and Drug Administration panel for the approximation of tissue layers where subcutaneous dead space exists between tissue planes in large flap surgical procedures such as abdominoplasty.

September 2014 | VOL. 13, NO. 9 | www.McGowan.pitt.edu

Use of TissuGlu® Surgical Adhesive in abdominoplasty procedures. –Cohera Medical, Inc.

Several years ago, McGowan Institute for Regenerative Medicine faculty member Eric Beckman, PhD, George M. Bevier Professor of Engineering in the University of Pittsburgh Department of Chemical and Petroleum Engineering, and Michael Buckley, MD, oral and maxillofacial surgeon, invented a novel medical adhesive technology. The new adhesive—now known as TissuGlu®—was designed to meet a market demand for a strong, safe tissue adhesive to improve the wound closure process. The product positions tissues for optimal healing while minimizing fluid accumulation. To move the University of Pittsburgh-developed technology towards clinical use, Cohera Medical, Inc. was formed, and the intellectual property was licensed by the University to Cohera.

Read More

Newsletters | August 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | August 29, 2014
hemolung0814

August 2014 | VOL. 13, NO. 8 | www.McGowan.pitt.edu

Technology Developed by McGowan Faculty Permitted the First U.S. Implant of a Medical Device Before Lifesaving Double Lung Transplant

Based on technology developed by McGowan Institute of Regenerative Medicine faculty members William Federspiel, PhD, W.K. Whiteford professor of bioengineering, chemical engineering, and critical care medicine, and the late Brack Hattler, MD, ALung Technologies developed the Hemolung Respiratory Assist System (RAS) as a dialysis-like alternative or supplement to mechanical ventilation.  Earlier this year, the Hemolung RAS was implanted into the first person in the U.S. at the University of Pittsburgh Medical Center (UPMC).  The device was used as a bridge to transplantation upon receiving the U.S. Food and Drug Administration’s approval to use the technology on a compassionate use basis.

Read More

Newsletters | July 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | July 31, 2014
Drs. Johnny Huard (top) and Donna Stolz

July 2014 | VOL. 13, NO. 7 | www.McGowan.pitt.edu

Stem Cells from Muscle Can Repair Nerve Damage After Injury

Stem cells derived from human muscle tissue were able to repair nerve damage and restore function in an animal model of sciatic nerve injury, according to McGowan Institute for Regenerative Medicine faculty members Johnny Huard, PhD, Professor in the Departments of Orthopaedic Surgery, Microbiology and Molecular Genetics, Bioengineering, Pathology, Pediatrics, and Physical Medicine and Rehabilitation and the Director of the Stem Cell Research Center, and Donna Stolz, PhD, Associate Director of the Center for Biologic Imaging, University of Pittsburgh School of Medicine, and Associate Professor in the Departments of Cell Biology and Pathology at the University of Pittsburgh, and researchers at the University of Pittsburgh School of Medicine. The findings, published in the Journal of Clinical Investigation, suggest that cell therapy of certain nerve diseases, such as multiple sclerosis, might one day be feasible.

Read More

Newsletters | June 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | June 30, 2014
Simon Watkins, PhD

June 2014 | VOL. 13, NO. 6 | www.McGowan.pitt.edu

Malfunction in Molecular ‘Proofreader’ Prevents Repair of UV-Induced DNA Damage

Malfunctions in the molecular “proofreading” machinery, which repairs structural errors in DNA caused by ultraviolet (UV) light damage, help explain why people who have the disease xeroderma pigmentosum (XP) are at an extremely high risk for developing skin cancer, according to McGowan Institute for Regenerative Medicine affiliated faculty member Simon Watkins, PhD, founder and director of the Center for Biologic Imaging and a professor and vice chairman within the Department of Cell Biology at the University of Pittsburgh, and researchers at the University of Pittsburgh School of Medicine and the University of Pittsburgh Cancer Institute (UPCI). Their findings are published in the online version of the Proceedings of the National Academy of Sciences.

Read More

Newsletters | May 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | May 30, 2014
Sheet of ECM

May 2014 | VOL. 13, NO. 5 | www.McGowan.pitt.edu

Regenerative Medicine Improves Muscle Strength and Function in Leg Injuries

Damaged leg muscles grew stronger and showed signs of regeneration in three out of five men whose old injuries were surgically implanted with extracellular matrix (ECM) derived from pig bladder (pictured), according to a new study conducted by McGowan Institute affiliated faculty. Early findings from a human trial of the process and from animal studies were published recently in Science Translational Medicine.

Read More

Newsletters | April 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | April 30, 2014
Untitled-21

April 2014 | VOL. 13, NO. 4 | www.McGowan.pitt.edu

Platelet-Rich Plasma and Fat Grafting: An Option?

A Leader in Immunogenetics

As reported by McGowan Institute for Regenerative Medicine faculty member co-authors J. Peter Rubin, MD, Chair of the Department of Plastic Surgery, UPMC Endowed Professor of Plastic Surgery, and Professor of Bioengineering at the University of Pittsburgh, Co-Director of the Adipose Stem Cell Center, and is Founder and Director of the Center for Innovation in Restorative Medicine in the Department of Surgery at the University of Pittsburgh, and Kacey Marra, PhD, Associate Professor, Department of Surgery at the University of Pittsburgh, Director of the Plastic Surgery Laboratory, and Co-Director of the Adipose Stem Cell Center, autologous fat grafting is an important treatment option for small to medium soft tissue defects derived from tumor ablation, congenital deformity, and traumatic injury. The advantages are that autologous fat is easy to obtain in large quantities and the procedure is less uncomfortable and risky to patients; the operation is of short duration, can sometimes be performed under local anesthesia, and simultaneously achieves an aesthetic result in both the donor and recipient sites. However, the disadvantages of fat grafting are an unpredictable and variable reabsorption rate of around 40%–60%, resulting in the need for repeated procedures, and microcalcifications and cyst formation due to fat necrosis. Reabsorption and fat necrosis are believed to be caused by insufficient neoangiogenesis around the fat graft, thus resulting in adipocyte apoptosis due to lack of nutrient supply and accumulation of metabolic waste.

Read More

Newsletters | March 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | March 31, 2014
Screen Shot 2015-09-14 at 9.47.56 AM

March 2014 | VOL. 13, NO. 3 | www.McGowan.pitt.edu

McGowan Institute Holds Its Annual Scientific Retreat

The McGowan Institute for Regenerative Medicine held its 2014 Scientific Retreat March 9-11, 2014. The focus was on peer-to-peer networking, and the retreat provided many opportunities to explore collaborative endeavors with other researchers, participating guests, and external partners who are working to bring regenerative medicine technologies to clinical use.

Read More

Newsletters | February 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | February 28, 2014
Untitled-30

February 2014 | VOL. 13, NO. 2 | www.McGowan.pitt.edu

Type 1 Diabetes: A Treatment’s In Sight?

A Leader in Immunogenetics

McGowan Institute for Regenerative Medicine faculty member Massimo Trucco, MD, is an international leader in the field of immunogenetics, having dedicated his life’s work to finding a cure for diabetes. Dr. Trucco is the Director of the Division of Immunogenetics at the Children’s Hospital of Pittsburgh of the University of Pittsburgh Medical Center, the Hillman Professor of Pediatric Immunology at Children’s Hospital, and a Professor of Pediatrics at the University of Pittsburgh School of Medicine.

Read More

Newsletters | January 2014

By The McGowan Institute For Regenerative Medicine | Newsletter, Newsletter 2014 | January 31, 2014
Untitled-42

January 2014 | VOL. 13, NO. 1 | www.McGowan.pitt.edu

Pioneering Initiative = Improved Standard of Care + Educational Success

On January 15, 2014, the UPMC Artificial Heart/Ventricular Assist Device (VAD) Program achieved a remarkable milestone: 100,000 cumulative days of circulatory support in 830 heart failure patients beginning in October 1985 through January 2014.

Read More

  • site map
  • links
  • contact
  • subscribe to our newsletter
© Copyright 2021 McGowan Institute for Regenerative Medicine
A program of the University of Pittsburgh and the University of Pittsburgh Medical Center
  • Home
  • Our People
    • Faculty/Staff Bios
    • Core Faculty Publications
    • Administrative Resources
  • Our Technologies
  • About Us
    • Welcome
    • Video
    • Statistics
    • Mission Statement
    • What Is Regenerative Medicine?
    • Executive Committee
    • Contact Us
    • Clinical Site
  • Our Research
    • Focus Areas
      • Tissue Engineering and Biomaterials
      • Cellular Therapies
      • Medical Devices and Artificial Organs
      • Clinical Translation
    • Matrix
    • Centers
    • Laboratories
    • Clinical Trials
    • Initiatives
  • Media
    • Current News
    • News Archive
    • Video
    • Podcasts
    • Newsletter
    • Grant of the Month
    • Publication of the Month
    • Media Contact
    • Video Links
  • Professional Development
    • Seminar Series
    • Special Events
    • Student Interest Groups
    • CATER
    • Post-Doctoral Opportunities
    • Career Opportunities
    • Wiegand Summer Internship
    • Admissions
    • Summer School
    • 2021 Scientific Retreat
    • Human Performance Optimization Conference
Regenerative Medicine at the McGowan Institute